Zevra Therapeutics Shares Fall After Negative CHMP Opinion on Arimoclomol for Niemann-Pick Disease

Final European Commission decision pending.

Zevra Therapeutics Shares Fall After Negative CHMP Opinion on Arimoclomol for Niemann-Pick Disease
Credit: Zevra Therapeutics
Already have an account? Sign in.